MELD-XI: A rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapy
Top Cited Papers
Open Access
- 27 December 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 13 (1), 30-37
- https://doi.org/10.1002/lt.20906
Abstract
Priority for “sickest first” liver transplantation (LT) in the United States is determined by the model for end-stage liver disease (MELD). MELD is a good predictor of short-term mortality in cirrhosis, but it can overestimate risk when international normalized ratio (INR) is artificially elevated by anticoagulation. An alternate prognostic index omitting INR is needed in this situation. We retrospectively analyzed survival data for 554 cirrhotic veterans referred for consideration of LT prior to December 1, 2003 (training group). Using logistic regression we derived a predictive formula for 90-day pretransplant mortality incorporating bilirubin and creatinine but omitting INR. We normalized this formula to the same scale as MELD using linear regression. This yielded MELD-XI (for MELD excluding INR) = 5.11 Ln(bilirubin) + 11.76 Ln(creatinine) + 9.44. Accuracy of MELD-XI was validated in a holdout group of 278 cirrhotic veterans referred after December 1, 2003, and in an independent validation dataset of 7,203 cirrhotic adults listed for LT in the United States between May 1, 2001, and October 31, 2001. MELD-XI and MELD correlated well in training, holdout, and independent validation cohorts (r = 0.930, 0.954, and 0.902, respectively). In the holdout cohort, c-statistics of MELD vs. MELD-XI for mortality were, respectively, 0.939 vs. 0.906 at 30 days;0.860 vs. 0.841 at 60 days; 0.842 vs. 0.829 at 90 days; and 0.795 vs. 0.797 at 180 days. In the independent validation dataset, c-statistics for MELD vs. MELD-XI as predictors of 90-day survival were, respectively, 0.857 vs. 0.843 in noncholestatic liver diseases and 0.905 vs. 0.894 in cholestatic liver diseases. Comparable MELD and MELD-XI scores were associated with comparable prognosis. In conclusion, MELD-XI, despite omission of INR, is nearly as accurate as MELD in predicting short-term survival in cirrhosis. In patients treated with oral anticoagulants, substitution of MELD-XI for MELD may permit more accurate assessment of risk and more rational assignment of “sickest first” priority for LT. Liver Transpl, 2007. © 2006 AASLD.Keywords
This publication has 18 references indexed in Scilit:
- Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis?Alimentary Pharmacology & Therapeutics, 2005
- Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD aloneLiver Transplantation, 2005
- Serum sodium predicts mortality in patients listed for liver transplantationHepatology, 2004
- Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early deathHepatology, 2004
- Improving liver allocation: MELD and PELDAmerican Journal of Transplantation, 2004
- Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answerGastroenterology, 2003
- Model for end-stage liver disease (MELD) and allocation of donor liversGastroenterology, 2003
- MELD and PELD: Application of survival models to liver allocationLiver Transplantation, 2001
- A model to predict survival in patients with end-stage liver diseaseHepatology, 2001
- A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shuntsHepatology, 2000